Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Sipp

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Cell Stem Cell|April 9, 2016
Undertested and Overpriced: Japan Issues First Conditional Approval of Stem Cell ProductChristopher McCabe, Douglas Sipp
Nature|June 24, 2016
Bioethics in China: No wild eastDouglas Sipp, Duanqing Pei
Cell Stem Cell|February 4, 2018
Japan Strengthens Regenerative Medicine OversightDouglas Sipp, Hideyuki Okano
Science (New York, N.Y.)|March 21, 2009
Medicine. Monitoring and regulating offshore stem cell clinicsSorapop Kiatpongsan, Douglas Sipp
Science (New York, N.Y.)|December 11, 2012
Stem cells. U.S. regulation of stem cells as medical productsDouglas Sipp, Leigh Turner
Nature|June 24, 2014
Regulation: Sell help not hopePaolo Bianco, Douglas Sipp
International Journal of Hematology|April 6, 2011
New IJH guidelines highlight greater transparencyDouglas Sipp, Toshio Suda
Science (New York, N.Y.)|August 17, 2019
Downgrading of regulation in regenerative medicineDouglas Sipp, Margaret Sleeboom-Faulkner
The New England Journal of Medicine|January 11, 2018
Rejuvenating Regenerative Medicine RegulationR Alta Charo, Douglas Sipp
Science (New York, N.Y.)|June 23, 2018
Emerging stem cell ethicsDouglas Sipp, Megan Munsie, Jeremy Sugarman
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Cell Stem Cell|April 9, 2016
Undertested and Overpriced: Japan Issues First Conditional Approval of Stem Cell ProductChristopher McCabe, Douglas Sipp
Nature|June 24, 2016
Bioethics in China: No wild eastDouglas Sipp, Duanqing Pei
Cell Stem Cell|February 4, 2018
Japan Strengthens Regenerative Medicine OversightDouglas Sipp, Hideyuki Okano
Science (New York, N.Y.)|March 21, 2009
Medicine. Monitoring and regulating offshore stem cell clinicsSorapop Kiatpongsan, Douglas Sipp
Science (New York, N.Y.)|December 11, 2012
Stem cells. U.S. regulation of stem cells as medical productsDouglas Sipp, Leigh Turner
Nature|June 24, 2014
Regulation: Sell help not hopePaolo Bianco, Douglas Sipp
International Journal of Hematology|April 6, 2011
New IJH guidelines highlight greater transparencyDouglas Sipp, Toshio Suda
Science (New York, N.Y.)|August 17, 2019
Downgrading of regulation in regenerative medicineDouglas Sipp, Margaret Sleeboom-Faulkner
The New England Journal of Medicine|January 11, 2018
Rejuvenating Regenerative Medicine RegulationR Alta Charo, Douglas Sipp
Science (New York, N.Y.)|June 23, 2018
Emerging stem cell ethicsDouglas Sipp, Megan Munsie, Jeremy Sugarman
Pageof 6